Issue link: http://viewer.e-digitaledition.com/i/1039517
Greetings, and welcome to MD News Central Pennsylvania. In this issue, we spotlight the leading-edge care available locally at Penn State Cancer Institute and Penn State Health St. Joseph Cancer Center — care that extends lives and enhances quality of life. One of our features offers an in-depth view of CAR-T cell therapy, an immunotherapy that is considered one of the most exciting advances in oncology in recent decades. In our region, only Penn State Cancer Institute offers this treatment, which is for certain adults with lymphoma who have exhausted other options. CAR-T cell therapy utilizes Yescarta, produced by Kite Pharma and approved by the FDA in October 2017 as only the second gene therapy available in the U.S. Yescarta modifies patients' own T cells to attack their cancer. Also underscoring Penn State Cancer Institute's com- mitment to advanced, evidence-based care, we spotlight the exercise oncology program, which actively engages patients in their course of treatment. The program leverages the meticulously documented benefits of exercise — including symptom relief and enhanced outcomes — for a wide range of patients. Another feature discusses yttrium-90 selective internal radiation therapy (Y-90 SIRT). In combination with conventional treatments, tissue-sparing Y-90 SIRT can improve outcomes for many patients who have liver cancer. The minimally invasive treatment is available at Penn State Health St. Joseph Cancer Center, sparing area patients the need to travel to large metropolitan facilities. In our clinical section about oncology, we focus on research suggesting exposure to thirdhand smoke may raise the risk of lung cancer. We also review findings that adolescents and young adults with acute lymphoblastic leukemia have a survival advantage if they are treated in pediatric cancer centers. Additionally, we offer a trove of statistics about oncology, as well as tips on practice management and news on up-and-coming medical devices. I am excited to share the perspectives of experts at Penn State Cancer Institute and Penn State Health St. Joseph Cancer Center about state-of-the-art treatments available in our region. Happy autumn! Susan Ecenbarger Publisher: Susan Ecenbarger Managing Editor: Steve Barrett President: Eric Silberman Chief Marketing Officer: Jason Skinner Vice President of Creative Services: Eric Jackson Vice President of Operations: Tyler Hardekopf In Memoriam: Robert J. Brennan, Founder Account Manager: Jenn Taylor Designer: Michael Simmons Creative Services: Erika Bennett, Mariela Cosentino, Sarah Fredriksson, Jenny Havron, Emily Main, Jennifer Oncay, Kimmi Patterson, David Smith Production: Wade Sain Financial Services: Ashley Byrd Audience Development: Debbie Dodski MD News is published by True North Custom 1301 Riverfront Parkway, Suite 112 Chattanooga, TN 37402 423-266-3234 | truenorthcustom.com Although ever y precaution is taken to ensure accuracy of published materials, MD News cannot be held responsible for opinions expressed or facts supplied by its authors. Copyright 2018, True North Custom. All rights reser ved. Reproduction in whole or in part without written permission is prohibited. The healthcare providers featured in MD News comply with applicable Federal laws and do not discriminate on the basis of race, color, national origin, age, disability or sex. P O S T M A S T E R : Please send notices on Form 3579 to 1301 Riverfront Parkway, Suite 112, Chattanooga, TN 37402. Contact Information Send press releases and all other information related to this local edition of MD News to secenbarger @mdnews.com or via fax to 717-4 82-8186. Central Pennsylvania 05-868 PUBLISHER from the ............................................... Susan Ecenbarger PUBLISHER Central Pennsylvania ............................................... secenbarger@mdnews.com 717-575-6691 ............................................... @MDNewsCentralPA